Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 48Breast Neoplasms 8Neoplasms 4Leiomyoma 3Breast Neoplasms, Male 2Sexual Dysfunction, Physiological 1Prostate Adenocarcinoma 1Neoplasm Metastasis 1Myofibroma 1Breast Cancer Invasive 1Advanced Prostate Cancer 1Advanced Prostate Adenocarcinoma 1Adenocarcinoma 1

Interventions

Leuprolide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Advanced Prostate Adenocarcinoma × Leuprolide × Clear all
NCT04914195 2023-08-01

Leuprolide Acetate 3.75 mg Depot Injection for Patients With Advanced Prostate Cancer

Bharat Serums and Vaccines Limited

Phase 3 Completed
155 enrolled
Genitourinary

Advanced Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡